- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03912922
SIT LESS 4: How Does Reducing Sitting Time Improve Glucose and Lipid Metabolism? (SITLESS4)
SIT LESS 4: How Does Reducing Sitting Time Improve Glucose and Lipid Metabolism? A Study to Identify Underlying Mechanisms
Research has shown that replacing sitting time with low intensity physical activity (such as slowly walking and standing) has beneficial effects on metabolic health, like insulin sensitivity, comparable to improvements after sitting all day in combination with 1h streneous exercise.
The main objective of this study is to investigate the underlying mechanisms responsible for improved insulin sensitivity after 4 days of sitting less compared to sitting and exercise in healthy obese women. Our secondary objective is to investigate the effects of sitting less on cardio metabolic parameters.
Studieoversikt
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Maastricht, Nederland
- Maastricht University Medical Centre
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Signed informed consent
- Caucasian
- Postmenopausal women
- Aged 45-70 years at start of the study
- Body mass index (BMI) 25 - 35 kg/m2
- Stable dietary habits (no weight loss or gain >5kg in the past 3 months)
- Sedentary lifestyle (not more than 2,5 hours of exercise per week in the past 3 months)
Exclusion Criteria:
- Not able to complete the sitless try-out day according to the protocol
- Active diseases (cardiovascular, diabetes, liver, kidney, cancer or other)
- No use of medication interfering with investigated study parameters (as determined by responsible physician)
- Alcohol consumption of >2 servings per day
- Smoking in the past 6 months
- Participation in another biomedical trial which may have an effect on insulin sensitivity less than one month before the start of the study (screening visit)
- Mental or physical disability which interferes with physical activity
- Subjects with contra-indications for magnetic resonance imaging (MRI)
- Reported participation in night shift work 2 weeks prior to the start of the study (screening visit) and during study participation. Night work is defined as working between midnight and 6.00 AM.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Crossover-oppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Sit regime
Subjects will follow the sit regime during four days.
Each day consists of 14 hours sitting, 1 hour walking and 1 hour standing and 8 hours sleeping.
|
Activity regime of 4 days followed by a test day.
|
|
Eksperimentell: Sit less regime
Subjects will follow the sit less regime during four days.
Each day will consist of 9 hours sitting, 3 hours walking, 4 hours standing and 8 hours sleeping.
|
Activity regime of 4 days followed by a test day.
|
|
Eksperimentell: Exercise regime
Subjects will follow the exercise regime during four days.
Each day will consist of 13 hours sitting, 1 hour walking, 1 hour standing, 1 hour exercise and 8 hours sleeping.
The cycle session will be at approximately 60% maximal power.
Exact cycling intensity and duration will be calculated to ensure equal total energy expenditure between the sitting less and the exercise regime.
|
Activity regime of 4 days followed by a test day.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Insulin sensitivity
Tidsramme: Day 5 of intervention period
|
2-step hyperinsulinemic euglycemic clamp
|
Day 5 of intervention period
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
ex vivo skeletal muscle mitochondrial respiration
Tidsramme: Day 5 of intervention period
|
oxygraph
|
Day 5 of intervention period
|
|
substrate oxidation
Tidsramme: Day 5 of intervention period
|
indirect calorimetry RER
|
Day 5 of intervention period
|
|
Intrahepatic lipid content
Tidsramme: Day 5 of intervention period
|
magnetic resonance spectroscopy
|
Day 5 of intervention period
|
|
Blood pressure
Tidsramme: Day 5 of intervention period
|
average resting blood pressure over 30 minutes
|
Day 5 of intervention period
|
|
Plasma cardio metabolic markers
Tidsramme: Day 5 of intervention period
|
endothelial dysfunction score (average Z-score of log transformed plasma sVCAM1, sICAM1 and sE-selectin)
|
Day 5 of intervention period
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- NL62413.068.17
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .